ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
Overall ABL gets a fundamental rating of 6 out of 10. We evaluated ABL against 64 industry peers in the Health Care Equipment & Supplies industry. ABL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ABL has a correct valuation and a medium growth rate. This makes ABL very considerable for quality investing!
1. Profitability
1.1 Basic Checks
ABL had positive earnings in the past year.
In the past year ABL had a positive cash flow from operations.
ABL had positive earnings in each of the past 5 years.
In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 16.58%, ABL belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
With an excellent Return On Equity value of 27.66%, ABL belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
The Return On Invested Capital of ABL (9.27%) is better than 73.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 8.65%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| ROIC | 9.27% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
With an excellent Profit Margin value of 31.89%, ABL belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
ABL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 17.45%, ABL is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
In the last couple of years the Operating Margin of ABL has grown nicely.
ABL has a Gross Margin of 56.10%. This is comparable to the rest of the industry: ABL outperforms 46.88% of its industry peers.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.45% | ||
| PM (TTM) | 31.89% | ||
| GM | 56.1% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
ABL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.07 indicates that ABL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.07, ABL belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
ABL has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
ABL has a Debt to FCF ratio of 1.99. This is amongst the best in the industry. ABL outperforms 82.81% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABL is not too dependend on debt financing.
The Debt to Equity ratio of ABL (0.26) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 6.07 |
ROIC/WACC1.06
WACC8.74%
2.3 Liquidity
ABL has a Current Ratio of 1.78. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
ABL's Current ratio of 1.78 is in line compared to the rest of the industry. ABL outperforms 53.13% of its industry peers.
A Quick Ratio of 1.27 indicates that ABL should not have too much problems paying its short term obligations.
ABL has a Quick ratio of 1.27. This is in the better half of the industry: ABL outperforms 60.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.88%, which is quite good.
ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.59% yearly.
ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.00%.
Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)8.88%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%11.22%
Revenue 1Y (TTM)5%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%3.95%
3.2 Future
Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.62% on average per year.
The Revenue is expected to grow by 7.19% on average over the next years.
EPS Next Y11.56%
EPS Next 2Y10.84%
EPS Next 3Y10.71%
EPS Next 5Y9.62%
Revenue Next Year6.4%
Revenue Next 2Y7.04%
Revenue Next 3Y7.21%
Revenue Next 5Y7.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 28.16 indicates a quite expensive valuation of ABL.
Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 73.44% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (26.60), we can say ABL is valued inline with the index average.
The Price/Forward Earnings ratio is 23.46, which indicates a rather expensive current valuation of ABL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 62.50% of the companies listed in the same industry.
ABL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.16 | ||
| Fwd PE | 23.46 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 64.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.18 | ||
| EV/EBITDA | 22.63 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.44
PEG (5Y)3.71
EPS Next 2Y10.84%
EPS Next 3Y10.71%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.76%, ABL has a reasonable but not impressive dividend return.
ABL's Dividend Yield is a higher than the industry average which is at 2.33.
Compared to the average S&P500 Dividend Yield of 2.39, ABL is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.92% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.92%
EPS Next 2Y10.84%
EPS Next 3Y10.71%
FRA:ABL (6/12/2025, 7:00:00 PM)
117.72
+0.64 (+0.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners79.14%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap204.81B
Analysts78.75
Price Target126.29 (7.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend1.94
Dividend Growth(5Y)11.4%
DP28.92%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.21%
Min EPS beat(2)-1.16%
Max EPS beat(2)0.73%
EPS beat(4)2
Avg EPS beat(4)0.36%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.22%
EPS beat(8)5
Avg EPS beat(8)0.86%
EPS beat(12)9
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)9.57%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-1.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)1.49%
Revenue beat(16)10
Avg Revenue beat(16)3.05%
PT rev (1m)0.85%
PT rev (3m)-2.94%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)0.07%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.05%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.16 | ||
| Fwd PE | 23.46 | ||
| P/S | 5.53 | ||
| P/FCF | 35.18 | ||
| P/OCF | 26.16 | ||
| P/B | 4.8 | ||
| P/tB | 12.2 | ||
| EV/EBITDA | 22.63 |
EPS(TTM)4.18
EY3.55%
EPS(NY)5.02
Fwd EY4.26%
FCF(TTM)3.35
FCFY2.84%
OCF(TTM)4.5
OCFY3.82%
SpS21.29
BVpS24.54
TBVpS9.65
PEG (NY)2.44
PEG (5Y)3.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| ROCE | 10.8% | ||
| ROIC | 9.27% | ||
| ROICexc | 10.3% | ||
| ROICexgc | 19.85% | ||
| OM | 17.45% | ||
| PM (TTM) | 31.89% | ||
| GM | 56.1% | ||
| FCFM | 15.72% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 72.36% | ||
| Cap/Sales | 5.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 84.75% | ||
| Profit Quality | 49.3% | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 6.07 |
F-Score7
WACC8.74%
ROIC/WACC1.06
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)8.88%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%11.22%
EPS Next Y11.56%
EPS Next 2Y10.84%
EPS Next 3Y10.71%
EPS Next 5Y9.62%
Revenue 1Y (TTM)5%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%3.95%
Revenue Next Year6.4%
Revenue Next 2Y7.04%
Revenue Next 3Y7.21%
Revenue Next 5Y7.19%
EBIT growth 1Y12%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year29.19%
EBIT Next 3Y15.9%
EBIT Next 5Y10.98%
FCF growth 1Y-2.43%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y3.36%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%